Melicent Peck • UCSF Profiles

Melicent Peck, MD, PhD

Title(s)	Attending Physician, Medicine
School	School of Medicine
Address	400 Parnassus Avenue, #A2204 San Francisco CA 94117
Phone	650-353-2626
vCard	Download vCard

Biography

Education and Training

University of California, Berkeley	BA, BS		Biochemistry
Stanford University	Ph.D.	2002	Biological Sciences
Stanford University	M.D.	2007	Medicine
Stanford University	Residency	2010	Internal Medicine
UCSF	Fellowship	2013	Infectious Diseases
UCSF	Certificate in Clinical Research	2014	Epidemiology and Biostatistics

Awards and Honors

2014

CROI Young Investigator Award

Overview

Melicent Peck is a board-certified infectious diseases physician. She completed her MD/PhD training and internal medicine residency at Stanford University, infectious diseases fellowship at UCSF, and the Advanced Training in Clinical Research certificate at UCSF. She currently leads the early clinical development of novel antibiotics against multi-drug resistant bacteria and contributes to strategies to ensure that new antibiotics reach patients. She also leads the early clinical development of new immunotherapies. She is an attending physician at the UCSF Infectious Diseases Clinic.

Interests

Infectious diseases, HIV immunopathogenesis, Host-microbe interactions, Clinical trials, Drug development

Bibliographic

Publications

Publications listed below are automatically derived from MEDLINE/PubMed and other sources, which might result in incorrect or missing publications. Researchers can login to make corrections and additions, or contact us for help. to make corrections and additions.

Altmetrics Details

PMC Citations indicate the number of times the publication was cited by articles in PubMed Central, and the Altmetric score represents citations in news articles and social media. (Note that publications are often cited in additional ways that are not shown here.) Fields are based on how the National Library of Medicine (NLM) classifies the publication's journal and might not represent the specific topic of the publication. Translation tags are based on the publication type and the MeSH terms NLM assigns to the publication. Some publications (especially newer ones and publications not in PubMed) might not yet be assigned Field or Translation tags.) Click a Field or Translation tag to filter the publications.

Astegolimab or Efmarodocokin Alfa in Patients With Severe COVID-19 Pneumonia: A Randomized, Phase 2 Trial. Crit Care Med. 2023 Jan 01; 51(1):103-116. Waters M, McKinnell JA, Kalil AC, Martin GS, Buchman TG, Theess W, Yang X, Lekkerkerker AN, Staton T, Rosenberger CM, Pappu R, Wang Y, Zhang W, Brooks L, Cheung D, Galanter J, Chen H, Mohan D, Peck MC, COVID-astegolimab-interleukin (IL) (COVASTIL) Study Group. PMID: 36519984.

View in: PubMed Mentions: 1 Fields:
Cri Critical Care
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of the Monoclonal Antibody MHAA4549A in Patients With Acute Uncomplicated Influenza A Infection. Open Forum Infect Dis. 2022 Feb; 9(2):ofab630. Lim JJ, Dar S, Venter D, Horcajada JP, Kulkarni P, Nguyen A, McBride JM, Deng R, Galanter J, Chu T, Newton EM, Tavel JA, Peck MC. PMID: 35106315; PMCID: PMC8801227.

View in: PubMed Mentions: 1
Pharmacokinetics of the Monoclonal Antibody MHAA4549A Administered in Combination With Oseltamivir in Patients Hospitalized With Severe Influenza A Infection. J Clin Pharmacol. 2020 11; 60(11):1509-1518. Deng R, She G, Maia M, Lim JJ, Peck MC, McBride JM, Kulkarni P, Horn P, Castro A, Newton E, Tavel JA, Hanley WD. PMID: 32621543; PMCID: PMC7586956.

View in: PubMed Mentions: 2 Fields:
Pha Pharmacology
Translation:Humans Cells CTClinical Trials
A Phase 2 Randomized, Double-Blind, Placebo-Controlled Trial of MHAA4549A, a Monoclonal Antibody, plus Oseltamivir in Patients Hospitalized with Severe Influenza A Virus Infection. Antimicrob Agents Chemother. 2020 06 23; 64(7). Lim JJ, Nilsson AC, Silverman M, Assy N, Kulkarni P, McBride JM, Deng R, Li C, Yang X, Nguyen A, Horn P, Maia M, Castro A, Peck MC, Galanter J, Chu T, Newton EM, Tavel JA. PMID: 32393496; PMCID: PMC7318030.

View in: PubMed Mentions: 10 Fields:
Ant Anti-Infective Agents
Translation:Humans Animals Cells CTClinical Trials
Risk stratification biomarkers for Staphylococcus aureus bacteraemia. Clin Transl Immunology. 2020; 9(2):e1110. Cao Y, Guimaraes AO, Peck MC, Mayba O, Ruffin F, Hong K, Carrasco-Triguero M, Fowler VG, Maskarinec SA, Rosenberger CM. PMID: 32082571; PMCID: PMC7018520.

View in: PubMed Mentions: 4
A Phase 1, Randomized, Single-Ascending-Dose Study To Investigate the Safety, Tolerability, and Pharmacokinetics of DSTA4637S, an Anti-Staphylococcus aureus Thiomab Antibody-Antibiotic Conjugate, in Healthy Volunteers. Antimicrob Agents Chemother. 2019 06; 63(6). Peck M, Rothenberg ME, Deng R, Lewin-Koh N, She G, Kamath AV, Carrasco-Triguero M, Saad O, Castro A, Teufel L, Dickerson DS, Leonardelli M, Tavel JA. PMID: 30910894; PMCID: PMC6535527.

View in: PubMed Mentions: 21 Fields:
Ant Anti-Infective Agents
Translation:Humans Cells CTClinical Trials
A Prognostic Model of Persistent Bacteremia and Mortality in Complicated Staphylococcus aureus Bloodstream Infection. Clin Infect Dis. 2019 04 24; 68(9):1502-1511. Guimaraes AO, Cao Y, Hong K, Mayba O, Peck MC, Gutierrez J, Ruffin F, Carrasco-Triguero M, Dinoso JB, Clemenzi-Allen A, Koss CA, Maskarinec SA, Chambers HF, Fowler VG, Baruch A, Rosenberger CM. PMID: 30165412; PMCID: PMC6481998.

View in: PubMed Mentions: 23 Fields:
Com Communicable Diseases
Translation:Humans Cells
Prognostic Power of Pathogen Cell-Free DNA in Staphylococcus aureus Bacteremia. Open Forum Infect Dis. 2019 Apr; 6(4):ofz126. Guimaraes AO, Gutierrez J, Maskarinec SA, Cao Y, Hong K, Ruffin F, Carrasco-Triguero M, Peck MC, Fowler VG, Baruch A, Rosenberger CM. PMID: 31041341; PMCID: PMC6483138.

View in: PubMed Mentions: 2
Sustained Circulating Bacterial Deoxyribonucleic Acid Is Associated With Complicated Staphylococcus aureus Bacteremia. Open Forum Infect Dis. 2019 Apr; 6(4):ofz090. Gutierrez J, Guimaraes AO, Lewin-Koh N, Berhanu A, Xu M, Cao Y, Kim J, Yan D, Chang JK, Dinoso JB, Koss CA, Clemenzi-Allen A, Chambers HF, Peck MC, Baruch A, Rosenberger CM. PMID: 31024970; PMCID: PMC6475589.

View in: PubMed Mentions: 4
Limited HIV infection of central memory and stem cell memory CD4+ T cells is associated with lack of progression in viremic individuals. PLoS Pathog. 2014 Aug; 10(8):e1004345. Klatt NR, Bosinger SE, Peck M, Richert-Spuhler LE, Heigele A, Gile JP, Patel N, Taaffe J, Julg B, Camerini D, Torti C, Martin JN, Deeks SG, Sinclair E, Hecht FM, Lederman MM, Paiardini M, Kirchhoff F, Brenchley JM, Hunt PW, Silvestri G. PMID: 25167059; PMCID: PMC4148445.

View in: PubMed Mentions: 54 Fields:
Mic Microbiology
Translation:Humans Cells
Isolation and characterization of mutant Sinorhizobium meliloti NodD1 proteins with altered responses to luteolin. J Bacteriol. 2013 Aug; 195(16):3714-23. Peck MC, Fisher RF, Bliss R, Long SR. PMID: 23772067; PMCID: PMC3754574.

View in: PubMed Mentions: 9 Fields:
Bac Bacteriology
Translation:Cells
Diverse flavonoids stimulate NodD1 binding to nod gene promoters in Sinorhizobium meliloti. J Bacteriol. 2006 Aug; 188(15):5417-27. Peck MC, Fisher RF, Long SR. PMID: 16855231; PMCID: PMC1540014.

View in: PubMed Mentions: 49 Fields:
Bac Bacteriology
Translation:Animals Cells
The RNA polymerase alpha subunit from Sinorhizobium meliloti can assemble with RNA polymerase subunits from Escherichia coli and function in basal and activated transcription both in vivo and in vitro. J Bacteriol. 2002 Jul; 184(14):3808-14. Peck MC, Gaal T, Fisher RF, Gourse RL, Long SR. PMID: 12081950; PMCID: PMC135166.

View in: PubMed Mentions: 5 Fields:
Bac Bacteriology
Translation:Cells
Luteolin and GroESL modulate in vitro activity of NodD. J Bacteriol. 2002 Jan; 184(2):525-30. Yeh KC, Peck MC, Long SR. PMID: 11751831; PMCID: PMC139556.

View in: PubMed Mentions: 18 Fields:
Bac Bacteriology
Translation:Cells
Nucleotide sequence and predicted functions of the entire Sinorhizobium meliloti pSymA megaplasmid. Proc Natl Acad Sci U S A. 2001 Aug 14; 98(17):9883-8. Barnett MJ, Fisher RF, Jones T, Komp C, Abola AP, Barloy-Hubler F, Bowser L, Capela D, Galibert F, Gouzy J, Gurjal M, Hong A, Huizar L, Hyman RW, Kahn D, Kahn ML, Kalman S, Keating DH, Palm C, Peck MC, Surzycki R, Wells DH, Yeh KC, Davis RW, Federspiel NA, Long SR. PMID: 11481432; PMCID: PMC55547.

View in: PubMed Mentions: 107 Fields:
Sci Science
Translation:Cells
The composite genome of the legume symbiont Sinorhizobium meliloti. Science. 2001 Jul 27; 293(5530):668-72. Galibert F, Finan TM, Long SR, Puhler A, Abola P, Ampe F, Barloy-Hubler F, Barnett MJ, Becker A, Boistard P, Bothe G, Boutry M, Bowser L, Buhrmester J, Cadieu E, Capela D, Chain P, Cowie A, Davis RW, Dreano S, Federspiel NA, Fisher RF, Gloux S, Godrie T, Goffeau A, Golding B, Gouzy J, Gurjal M, Hernandez-Lucas I, Hong A, Huizar L, Hyman RW, Jones T, Kahn D, Kahn ML, Kalman S, Keating DH, Kiss E, Komp C, Lelaure V, Masuy D, Palm C, Peck MC, Pohl TM, Portetelle D, Purnelle B, Ramsperger U, Surzycki R, Thebault P, Vandenbol M, Vorholter FJ, Weidner S, Wells DH, Wong K, Yeh KC, Batut J. PMID: 11474104.

View in: PubMed Mentions: 444 Fields:
Sci Science
Translation:Animals Cells